Xiao Y, Hassani M, Moghaddam M, Fazilat A, Ojarudi M, Valilo M
Med Oncol. 2025; 42(4):108.
PMID: 40087196
DOI: 10.1007/s12032-025-02675-8.
Bamodu O, Chung C, Pisanic 2nd T
J Liq Biopsy. 2025; 2:100126.
PMID: 40028482
PMC: 11863985.
DOI: 10.1016/j.jlb.2023.100126.
Li Y, Liu F, Cai Q, Deng L, OuYang Q, Zhang X
Signal Transduct Target Ther. 2025; 10(1):57.
PMID: 39979279
PMC: 11842613.
DOI: 10.1038/s41392-025-02148-4.
Chen J, Hu S, Liu J, Jiang H, Wang S, Yang Z
MedComm (2020). 2025; 6(3):e70095.
PMID: 39968497
PMC: 11831209.
DOI: 10.1002/mco2.70095.
Zhao Y, Yu H, Li J, Qian J, Li M, Zhang X
Nat Commun. 2025; 16(1):1736.
PMID: 39966385
PMC: 11836368.
DOI: 10.1038/s41467-025-56878-8.
Regulatory Roles of Exosomes in Aging and Aging-Related Diseases.
Xiao N, Li Q, Liang G, Qian Z, Lin Y, Zhang H
Biogerontology. 2025; 26(2):61.
PMID: 39966192
DOI: 10.1007/s10522-025-10200-7.
Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma.
Guan M, Wang M, Wang W, Li C, Yao L, Zhu H
Liver Res. 2025; 6(3):132-138.
PMID: 39958202
PMC: 11791807.
DOI: 10.1016/j.livres.2022.08.001.
Tumor-derived exosomal KPNA2 activates fibroblasts and interacts with KIFC1 to promote bladder cancer progression, a process inhibited by miR-26b-5p.
Yin C, Liufu C, Ye S, Zhu T, Jiang J, Wang M
Cell Mol Biol Lett. 2025; 30(1):20.
PMID: 39956902
PMC: 11830183.
DOI: 10.1186/s11658-025-00687-w.
Integrins as Key Mediators of Metastasis.
Caceres-Calle D, Torre-Cea I, Marcos-Zazo L, Carrera-Aguado I, Guerra-Paes E, Berlana-Galan P
Int J Mol Sci. 2025; 26(3).
PMID: 39940673
PMC: 11816423.
DOI: 10.3390/ijms26030904.
Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression.
Ge Y, Jiang L, Dong Q, Xu Y, Yam J, Zhong X
J Clin Transl Hepatol. 2025; 13(2):143-161.
PMID: 39917466
PMC: 11797817.
DOI: 10.14218/JCTH.2024.00302.
Myeloid cell-derived apCAFs promote HNSCC progression by regulating proportion of CD4 and CD8 T cells.
Ren F, Meng L, Zheng S, Cui J, Song S, Wang D
J Exp Clin Cancer Res. 2025; 44(1):33.
PMID: 39891284
PMC: 11783918.
DOI: 10.1186/s13046-025-03290-1.
Reprogramming of fibroblasts into cancer-associated fibroblasts via IGF2-mediated autophagy promotes metastasis of lung cancer cells.
Cao L, Li B, Zheng S, Zhang Q, Qian Y, Ren Y
iScience. 2025; 27(12):111269.
PMID: 39759028
PMC: 11700637.
DOI: 10.1016/j.isci.2024.111269.
miR-1247-3p regulation of CCND1 affects chemoresistance in colorectal cancer.
Wang D, Wang J, Yao F, Xie Z, Wu J, Chen H
PLoS One. 2024; 19(12):e0309979.
PMID: 39739897
PMC: 11687890.
DOI: 10.1371/journal.pone.0309979.
The therapeutic potential of RNA m(6)A in lung cancer.
Yu J, Sun W, Zhao X, Chen Y
Cell Commun Signal. 2024; 22(1):617.
PMID: 39736743
PMC: 11687105.
DOI: 10.1186/s12964-024-01980-5.
Exosomal long non-coding RNAs in lung cancer: A review.
Jiang J, Lin F, Wu W, Zhang Z, Zhang C, Qin D
Medicine (Baltimore). 2024; 103(51):e38492.
PMID: 39705424
PMC: 11666185.
DOI: 10.1097/MD.0000000000038492.
Mesenchymal Stem Cell-Exosomal miR-99a Attenuate Silica-Induced Lung Fibrosis by Inhibiting Pulmonary Fibroblast Transdifferentiation.
Hao X, Li P, Wang Y, Zhang Q, Yang F
Int J Mol Sci. 2024; 25(23).
PMID: 39684337
PMC: 11641662.
DOI: 10.3390/ijms252312626.
Recent Advances of Small Extracellular Vesicles for the Regulation and Function of Cancer-Associated Fibroblasts.
Liang C, Wang M, Huang Y, Yam J, Zhang X, Zhang X
Int J Mol Sci. 2024; 25(23).
PMID: 39684264
PMC: 11641781.
DOI: 10.3390/ijms252312548.
Integration of bioinformatics analysis reveals ZNF248 as a potential prognostic and immunotherapeutic biomarker for LIHC: machine learning and experimental evidence.
Weng L, Cheng Z, Qiu Z, Shi J, Chen L, He C
Am J Cancer Res. 2024; 14(11):5230-5250.
PMID: 39659932
PMC: 11626259.
DOI: 10.62347/CDUS5096.
Tumor exosomal RNPEP promotes lung metastasis of liver cancer via inducing cancer-associated fibroblast activation.
Chen Y, Pan G, Yang Y, Wu H, Weng M, Wu Q
Cancer Sci. 2024; 116(3):792-807.
PMID: 39658708
PMC: 11875778.
DOI: 10.1111/cas.16417.
Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies.
Ma Y, Zhang X, Liu C, Zhao Y
MedComm (2020). 2024; 5(12):e70009.
PMID: 39611045
PMC: 11604295.
DOI: 10.1002/mco2.70009.